J-PET enables and enhances applications across:

• Oncology — staging, recurrence, tumor metabolism
• Neurology — cognitive disorders, Alzheimer’s research
• Cardiology — viability, perfusion, inflammatory disease
• Pediatric Imaging — low-dose protocols
• Targeted Radioligand Therapy (Theranostics)
• Proton Therapy Monitoring
• Dual-Tracer Imaging

Theranostics is rapidly transforming cancer treatment—and J-PET is engineered to unlock imaging capabilities required for expanding alpha- and beta-radiopharmaceutical therapies.